【London Vet Show 2023】Nurturing Life, Safeguarding Health     Welcome to our booth!   The exhilarating 2023 London Vet Show in the United Kingdom has successfully concluded! It was a grand gathering in the field of veterinary medicine. During the exhibition, we came together with animal medical experts and practitioners from around the world, sharing the latest medical advancements and key breakthroughs. This unique platform provided us with extensive insights and profound expertise, igniting our passion for dedicating ourselves to the well-being of animals. The exhibition showcased numerous innovative technologies and treatment solutions in the field of animal medicine. From advanced diagnostic equipment to efficient surgical techniques, each exhibit represented a sincere concern for animal lives and the continuous progress within the field of veterinary medicine. At the London Vet Show, Getein came to this modern land and brought POCT, haematology and molecular diagnosis  products for veterinary, such as Getein 1100 vet, Getein 1160 vet, BHA-3000 vet, BHA-5000 vet, GN 7000 vet to the exhibition.  The staffs of Getein on the spot explained the excellent products to the visitors in detail with their enthusiastic attitudes and professional abilities, and showed the cutting-edge technological power of Getein to the world.     ACE products on show Molecular Diagnosis--GN 7000 Vet Akso PCR system PCR technology is used to detect pathogens at the genetic level, and to replicate and amplify low content nucleic acid fragments, which has higher sensitivity and specificity. Getein Animal focuses on the veterinary diagnosis and develops products suitable for pet hospitals. GN 7000 Vet is a compact and fully automated PCR lab that integrates nucleic acid release, PCR amplification, Real-Time detection and result analysis, providing your pets with a one-step POCT solution for nucleic acid detection.      Immunofluorescence Quantitative Analyzer--Getein 1100 vet    Getein 1100 Vet Immunofluorescence Quantitative Analyzer is a compact and accurate POCT analyzer that can be used as a reliable aid in clinical diagnostics for pets. With its high-quality testing results and instant testing as fast as 3 min, we are dedicated to provide better care  for your beloved pets.      Immunofluorescence Quantitative Analyzer--Getein 1160 vet   Getein 1160 Vet Immunofluorescence Quantitative Analyzer, which has has 4 incubation +1 emergency channels for simultaneous testing of multiple items and a constant temperature at 32℃ to ensure accurate test resultes, aids in detection for inflammation, cardiac, immune antibody, endocrine and infectious diseases, etc. in canines and felines to provide attentive care for your loving pets     Hematology--BHA 3000 vet (3-part differential)  、BHA 5000 vet(5-part differential)   5-part Differential with 23 Parameters, 3-part Differ...

  2024 Medlab Middle East—Powering Medical Laboratory Growth    01 Welcome to Medlab Middle East 2024   The Medlab Middle East is the largest laboratory equipment exhibition in the region, showcasing the latest products and cutting-edge technologies, attracting laboratory and diagnostic industry professionals from around the world, and has become a benchmark for the international laboratory equipment and testing industry. It is expected that the number of attendees in 2024 will reach 30000 or even more, which will become another grand event for knowledge sharing and cooperation building. 02 Exhibition Booth: Z5.E30 As one of the exhibitors of the Medlab Middle East, Getein Biotech will participate in this grand event from February 5th to 8th, 2024. As a biotechnology company dedicated to the research and production of in-vitro diagnostic reagents and instruments, we are committed to promoting innovation and development in medical laboratories, providing efficient solutions for the medical industry in the Middle East and other regions. 03 A Glance of Our Products!   At this exhibition, we will showcase the latest laboratory instruments, testing technologies, and product solutions. Our products cover multiple fields such as molecular diagnosis, immunofluorescence, biochemical analysis, and blood cell analysis, aiming to meet the different needs of medical laboratories. Our booth will serve as a platform for professionals to communicate and collaborate, providing industry experts and visitors with opportunities to learn about the latest trends, share experiences, and establish business connections. We sincerely invite you to visit our booth and witness the future of medical laboratory innovation together! Exhibition Name: Medlab Middle East 2024 Date: February 5th, 2024 to February 8th, 2024 Address: Dubai World Trade Center, United Arab Emirates   Booth Number: Z5.E30 Stay tuned for our exhibition updates and the latest product information. For more detailed information, please follow our official website or social media account. Let's step into the pulse of innovation in medical laboratories and create a better future together!        

Looking into the Future The First Overseas Distribution Partners Meeting of Getein Successfully Launched April 2, 2024 In April, when everything is recovering and growing, Getein Biotech held a grand distribution partners meeting in Manila, the capital of the Philippines, the country of a thousand islands. This is the first distribution partners meeting held by our company in 2024 in overseas market, and this historic day is fixed on April 2nd. This distribution partners meeting is not only to dine and communicate with distributors and partners who have been fighting side by side for a long time, but to tighten the deep friendship between each other and conclude new business alliance. Getein Biotech firmly believes that looking at the world at the critical time is a must for the company to thrive and grow. The first overseas distribution partners meeting is the key point of the grand chapter of Getein's layout of the global market. On the Spot   In April, when everything is recovering and growing, Getein Biotech held a grand distribution partners meeting in Manila, the capital of the Philippines, the country of a thousand islands. This is the first distribution partners meeting held by our company in 2024 in overseas market, and this historic day is fixed on April 2nd. This distribution partners meeting is not only to dine and communicate with distributors and partners who have been fighting side by side for a long time, but to tighten the deep friendship between each other and conclude new business alliance.   Getein Biotech firmly believes that looking at the world at the critical time is a must for the company to thrive and grow. The first overseas distribution partners meeting is the key point of the grand chapter of Getein's layout of the global market.   A series of well-planned communication sessions and interactive discussions not only deepened the mutual understanding with the distribution partners, but also laid a solid foundation of trust for the collaboration between us. In addition, Getein also took this opportunity to hope to work hand in hand with overseas partners to create a more brilliant future.     Between the Meeting    In order to recognize the outstanding achievements of the dealers, the distribution partners meeting will set up a special awards ceremony, not only as a recognition of their outstanding achievements, but also conveys an upward momentum to inspire all colleagues to continue to move forward.   Looking into the Future   In order to recognize the outstanding achievements of the dealers, the distribution partners meeting will set up a special awards ceremony, not only as a recognition of their outstanding achievements, but also conveys an upward momentum to inspire all colleagues to continue to move forward. In conclusion, the distribution partners meeting in Manila is not only a chance to communicate with our partners, but also signifies that Getein will integrate into...

2024 Bangladesh Distribution Partners Meeting Successfully Launched The Bangladesh Distribution Partners Meeting 2024, held on May 17th at The LE MERIDIEN DHAKA Hotel, marked a significant milestone for Getein Biotech in its efforts to strengthen relationships with local distributors and to promote its cutting-edge products, the MAGICL 6000/MAGICL 6000I and Metis 6000.   The meeting, which commenced at 4:00 PM, served as a platform for Getein Biotech to express gratitude towards its partners for their unwavering support and cooperation. It was also a strategic move to enhance the visibility and market penetration of its innovative medical devices in the Bangladesh market.   On the Spot Getein Biotech's staff took the lead in introducing the MAGICL 6000/MAGICL 6000I and Metis 6000 to an audience keen on understanding the capabilities and benefits of these state-of-the-art technologies. The MAGICL 6000, in particular, was demonstrated live, showcasing its operational excellence and user-friendliness. This hands-on demonstration was crucial in illustrating the practicality and efficiency of the device, which is expected to revolutionize diagnostic practices in healthcare settings. Between the Meeting The event also featured a session where experts shared their experiences with the MAGICL 6000. These testimonials provided valuable insights into the real-world applications of the device, highlighting its reliability and impact on improving patient outcomes. Such endorsements from the medical community are instrumental in building trust and credibility among potential users and partners. A pivotal moment of the meeting was the address by Catherine Xu, the International Trade Department Minister of Getein Biotech. She outlined the company's supportive policies for distributors, emphasizing the firm's commitment to fostering a conducive business environment for mutual growth. Her speech underscored the company's dedication to not only providing high-quality medical products but also ensuring that its partners are equipped with the necessary support to thrive in the competitive market. Looking into the Future The Bangladesh Distribution Partners Meeting 2024 was not just an event for product promotion but also an opportunity for Getein Biotech to listen to the feedback from local distributors. The company recognized the importance of understanding the unique challenges faced by its partners in Bangladesh and committed to engaging in an ongoing dialogue to address these issues. As the event concluded, the participants left with a deeper understanding of Getein Biotech's product offerings and a renewed sense of partnership. The meeting was a testament to Getein Biotech's strategic vision for long-term growth in the Bangladesh market and its resolve to work collaboratively with local distributors. The success of the Bangladesh Distribution Partners Meeting 2024 augurs well for Getein Biotech's future in the region. With a clear demonstrat...

Shaping the Future with Innovation   The 31st Balkan Clinical Laboratory Federation Meeting (BCLF) will be held in Türkiye from October 28 to November 1, 2024. The Balkan Clinical Laboratory Federation (BCLF) as a regional organization includes all Balkan countries, such as Albania, Bosnia and Herzegovina, Bulgaria, Greece, North Macedonia, Montenegro, Romania, Serbia, Turkey, that are also EFCC and IFCC members. As a regional organization，  BCLF gathers all clinical chemists from the Balkan region with the aim of improving clinical laboratory practice in each of the Balkan countries.   With the help of BCLF conference, you can refresh your knowledge base, explore innovations, exchange ideas, meet more partners. We believe that this conference will provide a valuable and unforgettable experience for all participants.   Exhibition Booth：NO.26 We announced that we will attend this highly anticipated industry conference from October 28 to November 1. We will display you our cutting-edge in vitro diagnostic equipment and reagents, as well as our innovative solutions for the in vitro diagnostic field. We expect to meet you in the beautiful Türkiye, and to experience the shock brought by technological progress and the infinite charm of innovative spirit.     We will showcase our latest in vitro diagnostic solutions including CLIA analyzer, immunofluorescence analyzers, molecular diagnostics platform and modular system, aiming to meet the diverse needs of various laboratories and medical institutions.   01   Exhibition Name：31st Balkan Clinical Laboratory Federation Meeting （BCLF） 02  Date：October 28 to November 1, 2024 03   Address：Starlight Convention Center, Side, Antalya, Türkiye  Booth: 26     We anticipate to have a face-to-face communication with you and discuss the latest achievements and unique advantages of Getein in the field of innovation deeply. Let us work together to explore the potential for future cooperation and jointly promote the advancement and development of diagnostic technology!  

Bridging Innovation Between East and West   On October 29th, Getein Biotech successfully held a grand distributor partners meeting  in the beautiful coastal city of Antalya,Turkey. The conference hosted by Getein Biotech in Turkey coincided with the National Day, adding a special significance to the event. In this moment of dual celebration, Getein Biotech conveyed a steadfast confidence in its future development and a hopeful outlook for international collaboration. This conference was not only aimed at forging new business alliances but also at deepening the bonds with our longstanding distributor partners through in-depth communication and collaboration.     The meeting and the 35th National Biochemical Congress in Turkey are both held in the same hotel. The on-site layout is exquisite and the atmosphere is enthusiastic. The meeting began with a warm and welcoming speech by Catherine Xu, Director of our International Trade Department. Catherine shared and exchanged cooperation experiences and common blueprints with old and new partners in attendance. Following this, Head of the Turkish market, Joe Qiu and Overseas Product Manager Veronika Wang introduced a series of innovative key products: the fully automated chemiluminescence analyzers MAGICL 6000 and MAGICL 6000i, the molecular diagnostic platform GN 7000, and the Metis 6000 Modular System. These products, with their groundbreaking technology and superior quality, showcased the company's remarkable strength and promising market prospects to the distributors. At the distributor partners meeting site, expert Dr. Cakmak enthusiastically shared his feelings and experiences of using MAGICL 6000 in the hospital with everyone. The guests under the stage listened attentively and actively communicated with the expert. Many of them agreed with the expert's views. The atmosphere at the scene was warm and pleasant.     A series of rich and fulfilling communication and interactive discussions not only deepened the mutual understanding with distributors but also laid a solid foundation of trust for the collaboration between both sides. Getein Biotech hopes to seize this opportunity to join hands with overseas partners to create a brighter future together.     As the tide rises in the East, Getein Biotech sets its sights on vast overseas territories. With years of experience in the domestic market, the company believes that looking outward at key moments is essential for robust growth. Looking ahead, Getein Biotech is confident that only through continuous innovation and proactive expansion can the company secure a place in the fiercely competitive global market. The successful hosting of this conference not only demonstrates Getein Biotech's firm confidence in further exploring international markets but also paves the way for the launch of a series of new products. Getein Biotech will continue to apply strategic foresight, cultivate deeply, and steadily naviga...